造血干细胞中糖原合成酶激酶3β（GSK3β）的缺失导致小鼠造血功能正常。 - Suppr

Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice.

作者信息

Lee Grace, Franklin Jude, Gupta Kalpana, Liu Ruifu, Zhou Lan, Ryder Christopher, Sobieraj Lukasz, Molitor Luke, Abiona Olubukola, Meyerson Howard, Das Indrani, Jackson Zachary, Wald David N

机构信息

Department of Pathology, Case Western Reserve University, Cleveland, OH.

Midwestern University Chicago College of Osteopathic Medicine, Downers Grove, IL.

出版信息

Blood Adv. 2023 Dec 12;7(23):7185-7189. doi: 10.1182/bloodadvances.2022008094.

DOI:10.1182/bloodadvances.2022008094

PMID:37922427

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10698258/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f8/10698258/e9fb9fcbbd2d/BLOODA_ADV-2022-008094-gr1.jpg

相似文献

Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice.

Blood Adv. 2023 Dec 12;7(23):7185-7189. doi: 10.1182/bloodadvances.2022008094.

Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice.

Stem Cells Dev. 2015 Mar 15;24(6):724-36. doi: 10.1089/scd.2014.0230. Epub 2014 Dec 9.

GSK3β regulates physiological migration of stem/progenitor cells via cytoskeletal rearrangement.

J Clin Invest. 2013 Apr;123(4):1705-17. doi: 10.1172/JCI64149. Epub 2013 Mar 8.

Effects of signaling pathway inhibitors on hematopoietic stem cells.

Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11647. Epub 2020 Nov 12.

Sulfatase modifying factor 1-mediated fibroblast growth factor signaling primes hematopoietic multilineage development.

J Exp Med. 2010 Aug 2;207(8):1647-60. doi: 10.1084/jem.20091022. Epub 2010 Jul 19.

Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.

Leuk Res. 2018 Feb;65:49-54. doi: 10.1016/j.leukres.2018.01.002. Epub 2018 Jan 2.

Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential.

Stem Cell Res Ther. 2017 Mar 17;8(1):67. doi: 10.1186/s13287-017-0519-0.

Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.

Blood. 2012 Mar 8;119(10):2335-45. doi: 10.1182/blood-2011-06-361261. Epub 2012 Jan 18.

GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells.

Stem Cell Reports. 2016 Feb 9;6(2):243-56. doi: 10.1016/j.stemcr.2015.12.010. Epub 2016 Jan 21.

Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.

Cancer Res. 2005 Apr 1;65(7):2537-41. doi: 10.1158/0008-5472.CAN-04-3011.

引用本文的文献

Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation.

Nature. 2025 Apr 16. doi: 10.1038/s41586-025-08915-1.

GSK3-Driven Modulation of Inflammation and Tissue Integrity in the Animal Model.

Int J Mol Sci. 2024 Jul 29;25(15):8263. doi: 10.3390/ijms25158263.

本文引用的文献

GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells.

J Cell Physiol. 2021 Jan;236(1):570-586. doi: 10.1002/jcp.29884. Epub 2020 Jun 22.

Aberrant GSK3β nuclear localization promotes AML growth and drug resistance.

Blood Adv. 2018 Nov 13;2(21):2890-2903. doi: 10.1182/bloodadvances.2018016006.

Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy.

Cancer Sci. 2016 Oct;107(10):1363-1372. doi: 10.1111/cas.13028. Epub 2016 Sep 24.

A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.

Mol Cancer Ther. 2016 Jul;15(7):1485-1494. doi: 10.1158/1535-7163.MCT-15-0566. Epub 2016 May 9.

Repression of GSK3 restores NK cell cytotoxicity in AML patients.

Nat Commun. 2016 Apr 4;7:11154. doi: 10.1038/ncomms11154.

GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia.

Cancer Cell. 2016 Jan 11;29(1):61-74. doi: 10.1016/j.ccell.2015.11.012.

Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis.

Cell Stem Cell. 2014 Dec 4;15(6):791-804. doi: 10.1016/j.stem.2014.11.002.

Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Pharmacol Ther. 2015 Apr;148:114-31. doi: 10.1016/j.pharmthera.2014.11.016. Epub 2014 Nov 27.

Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.

Leukemia. 2014 Jan;28(1):15-33. doi: 10.1038/leu.2013.184. Epub 2013 Jun 19.

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.

J Clin Invest. 2012 Mar;122(3):935-47. doi: 10.1172/JCI46465. Epub 2012 Feb 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献